Honigberg MC, Chang LS, McGuire DK, Plutzky J, Aroda VR, Vaduganathan M
The Glutathione Intervention: Tyrosinase Inhibition Mechanism Tyrosinase is a copper-containing enzyme that catalyzes the conversion of L-tyrosine into melanin
GLP-1 agonists were initially approved for treating type 2 diabetes, with subsequent approvals for chronic weight management and reduction of the risk of major cardiovascular events in patients with established cardiovascular disease and type 2 diabetes
doi: 10.2337/DB20-0636 Summary Keywords autoimmunity, coxsackievirus B (CVB), enterovirus, HLA, immune tolerance, stem cell-derived islets, type I interferon (IFN), cells Citation Veronese-Paniagua DA and Millman JR (2025) The perfect storm: unraveling the interplay of genetic predisposition and viral triggers in type 1 diabetes pathogenesis